Similar articles for PMID: 26721820

Year	Number of Results
1993	1
1994	2
1995	1
1997	1
2002	1
2004	1
2005	2
2006	1
2007	1
2008	2
2009	2
2010	1
2011	4
2012	4
2013	5
2014	5
2015	21
2016	16
2017	13
2018	6
2019	3
2020	4
2021	3
2022	1
2023	3
2024	0

1

Precision Cancer Medicine in the Acoustic Dispensing Era: Ex Vivo Primary Cell Drug Sensitivity Testing.

Kulesskiy E, Saarela J, Turunen L, Wennerberg K. Kulesskiy E, et al. J Lab Autom. 2016 Feb;21(1):27-36. doi: 10.1177/2211068215618869. Epub 2015 Dec 2. J Lab Autom. 2016. PMID: 26721820

2

Ex Vivo Assessment of Drug Activity in Patient Tumor Cells as a Basis for Tailored Cancer Therapy.

Blom K, Nygren P, Alvarsson J, Larsson R, Andersson CR. Blom K, et al. J Lab Autom. 2016 Feb;21(1):178-87. doi: 10.1177/2211068215598117. Epub 2015 Aug 5. J Lab Autom. 2016. PMID: 26246423

3

Predictive Value of Ex Vivo Chemosensitivity Assays for Individualized Cancer Chemotherapy: A Meta-Analysis.

Blom K, Nygren P, Larsson R, Andersson CR. Blom K, et al. SLAS Technol. 2017 Jun;22(3):306-314. doi: 10.1177/2472630316686297. Epub 2017 Jan 31. SLAS Technol. 2017. PMID: 28378608

4

Unlocking the Potential of High-Throughput Drug Combination Assays Using Acoustic Dispensing.

Chan GK, Wilson S, Schmidt S, Moffat JG. Chan GK, et al. J Lab Autom. 2016 Feb;21(1):125-32. doi: 10.1177/2211068215593759. Epub 2015 Jul 9. J Lab Autom. 2016. PMID: 26160862

5

Individualized systems medicine strategy to tailor treatments for patients with chemorefractory acute myeloid leukemia.

Pemovska T, Kontro M, Yadav B, Edgren H, Eldfors S, Szwajda A, Almusa H, Bespalov MM, Ellonen P, Elonen E, Gjertsen BT, Karjalainen R, Kulesskiy E, Lagström S, Lehto A, Lepistö M, Lundán T, Majumder MM, Marti JM, Mattila P, Murumägi A, Mustjoki S, Palva A, Parsons A, Pirttinen T, Rämet ME, Suvela M, Turunen L, Västrik I, Wolf M, Knowles J, Aittokallio T, Heckman CA, Porkka K, Kallioniemi O, Wennerberg K. Pemovska T, et al. Cancer Discov. 2013 Dec;3(12):1416-29. doi: 10.1158/2159-8290.CD-13-0350. Epub 2013 Sep 20. Cancer Discov. 2013. PMID: 24056683

6

[Progress of individualized chemotherapy guided by chemosensitivity test].

Mi YJ, Zhang CZ, Fu LW. Mi YJ, et al. Yao Xue Xue Bao. 2009 Nov;44(11):1187-92. Yao Xue Xue Bao. 2009. PMID: 21355317 Review. Chinese.

7

Drug sensitivity testing platforms for gastric cancer diagnostics.

Lau V, Wong AL, Ng C, Mok Y, Lakshmanan M, Yan B. Lau V, et al. J Clin Pathol. 2016 Feb;69(2):93-6. doi: 10.1136/jclinpath-2015-203426. Epub 2015 Nov 13. J Clin Pathol. 2016. PMID: 26567318 Review.

8

Culture and Drug Profiling of Patient Derived Malignant Pleural Effusions for Personalized Cancer Medicine.

Ruiz C, Kustermann S, Pietilae E, Vlajnic T, Baschiera B, Arabi L, Lorber T, Oeggerli M, Savic S, Obermann E, Singer T, Rothschild SI, Zippelius A, Roth AB, Bubendorf L. Ruiz C, et al. PLoS One. 2016 Aug 22;11(8):e0160807. doi: 10.1371/journal.pone.0160807. eCollection 2016. PLoS One. 2016. PMID: 27548442 Free PMC article.

9

Comparison of two supporting matrices for patient-derived cancer cells in 3D drug sensitivity and resistance testing assay (3D-DSRT).

Feodoroff M, Mikkonen P, Turunen L, Hassinen A, Paasonen L, Paavolainen L, Potdar S, Murumägi A, Kallioniemi O, Pietiäinen V. Feodoroff M, et al. SLAS Discov. 2023 Jun;28(4):138-148. doi: 10.1016/j.slasd.2023.03.002. Epub 2023 Mar 20. SLAS Discov. 2023. PMID: 36934951 Free article.

10

The AutoDiSC: development and validation of a novel chemotherapy sensitivity and resistance assay.

Schinköthe T, Thiruchittampalam D, Schmidt A, Bomholt N, Staib P. Schinköthe T, et al. Anticancer Res. 2013 Jun;33(6):2491-8. Anticancer Res. 2013. PMID: 23749900

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

88 results

Results by year